Literature DB >> 27341810

Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study.

E A Marques1, V Gudnason2,3, T Lang4, G Sigurdsson2,3,5, S Sigurdsson2, T Aspelund2,6, K Siggeirsdottir2, L Launer7, G Eiriksdottir2, T B Harris7.   

Abstract

Association between serum bone formation and resorption markers and cortical and trabecular bone loss and the concurrent periosteal apposition in a population-based cohort of 1069 older adults was assessed. BTM levels moderately reflect the cellular events at the endosteal and periosteal surfaces but are not associated with fracture risk.
INTRODUCTION: We assessed whether circulating bone formation and resorption markers (BTM) were individual predictors for trabecular and cortical bone loss, periosteal expansion, and fracture risk in older adults aged 66 to 93 years from the AGES-Reykjavik study.
METHODS: The sample for the quantitative computed tomography (QCT)-derived cortical and trabecular BMD and periosteal expansion analysis consisted of 1069 participants (474 men and 595 women) who had complete baseline (2002 to 2006) and follow-up (2007 to 2011) hip QCT scans and serum baseline BTM. During the median follow-up of 11.7 years (range 5.4-12.5), 54 (11.4 %) men and 182 (30.6 %) women sustained at least one fracture of any type.
RESULTS: Increase in BTM levels was associated with faster cortical and trabecular bone loss at the femoral neck and proximal femur in men and women. Higher BTM levels were positively related with periosteal expansion rate at the femoral neck in men. Markers were not associated with fracture risk.
CONCLUSION: This data corroborates the notion from few previous studies that both envelopes are metabolically active and that BTM levels may moderately reflect the cellular events at the endosteal and periosteal surfaces. However, our results do not support the routine use of BTM to assess fracture risk in older men and women. In light of these findings, further studies are justified to examine whether systemic markers of bone turnover might prove useful in monitoring skeletal remodeling events and the effects of current osteoporosis drugs at the periosteum.

Entities:  

Keywords:  Aging; Bone turnover; Endosteal bone loss; Fracture risk; Periosteal apposition; QCT

Mesh:

Substances:

Year:  2016        PMID: 27341810      PMCID: PMC5560053          DOI: 10.1007/s00198-016-3675-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

Review 1.  Toward an expanded understanding of the role of the periosteum in skeletal health.

Authors:  Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2003-06       Impact factor: 6.741

Review 2.  Bone modeling and remodeling.

Authors:  Ego Seeman
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

3.  Biochemical markers of bone formation reflect endosteal bone loss in elderly men--MINOS study.

Authors:  P Szulc; P Garnero; F Marchand; F Duboeuf; P D Delmas
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

4.  Human femoral neck has less cellular periosteum, and more mineralized periosteum, than femoral diaphyseal bone.

Authors:  Matthew R Allen; David B Burr
Journal:  Bone       Date:  2005-02       Impact factor: 4.398

5.  Rapid bone loss is associated with increased levels of biochemical markers.

Authors:  P D Ross; W Knowlton
Journal:  J Bone Miner Res       Date:  1998-02       Impact factor: 6.741

6.  Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.

Authors:  Rajesh Shigdel; Marit Osima; Luai A Ahmed; Ragnar M Joakimsen; Erik F Eriksen; Roger Zebaze; Åshild Bjørnerem
Journal:  Bone       Date:  2015-06-22       Impact factor: 4.398

7.  Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics.

Authors:  Tamara B Harris; Lenore J Launer; Gudny Eiriksdottir; Olafur Kjartansson; Palmi V Jonsson; Gunnar Sigurdsson; Gudmundur Thorgeirsson; Thor Aspelund; Melissa E Garcia; Mary Frances Cotch; Howard J Hoffman; Vilmundur Gudnason
Journal:  Am J Epidemiol       Date:  2007-03-10       Impact factor: 4.897

8.  Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction.

Authors:  L Joseph Melton; Cynthia S Crowson; W Michael O'Fallon; Heinz W Wahner; B Lawrence Riggs
Journal:  J Bone Miner Res       Date:  2003-02       Impact factor: 6.741

9.  Age and distance from the surface but not menopause reduce osteocyte density in human cancellous bone.

Authors:  S Qiu; D S Rao; S Palnitkar; A M Parfitt
Journal:  Bone       Date:  2002-08       Impact factor: 4.398

10.  Lathyrism-induced alterations in collagen cross-links influence the mechanical properties of bone material without affecting the mineral.

Authors:  E P Paschalis; D N Tatakis; S Robins; P Fratzl; I Manjubala; R Zoehrer; S Gamsjaeger; B Buchinger; A Roschger; R Phipps; A L Boskey; E Dall'Ara; P Varga; P Zysset; K Klaushofer; P Roschger
Journal:  Bone       Date:  2011-09-02       Impact factor: 4.398

View more
  12 in total

Review 1.  Bone health in ageing men.

Authors:  Karel David; Nick Narinx; Leen Antonio; Pieter Evenepoel; Frank Claessens; Brigitte Decallonne; Dirk Vanderschueren
Journal:  Rev Endocr Metab Disord       Date:  2022-07-16       Impact factor: 9.306

2.  Do bone turnover markers reflect changes in bone microarchitecture during treatment of patients with thyroid dysfunction?

Authors:  C J Vinther; L H Poulsen; P Nicolaisen; M L Obling; T H Brix; A P Hermann; L Hegedüs; N R Jørgensen; S Hansen; S J Bonnema
Journal:  J Endocrinol Invest       Date:  2022-09-05       Impact factor: 5.467

3.  Insulin-like growth factor binding protein 2 null mice (Igfbp2-/-) are protected against trabecular bone loss after vertical sleeve gastrectomy.

Authors:  Benjamin T Harris; Phuong T Le; Janaina Da Silva Martins; Lama Alabdulaaly; Roland Baron; Mary L Bouxsein; Clifford J Rosen; Alison N Pletch
Journal:  Surg Endosc       Date:  2022-02-28       Impact factor: 3.453

4.  Accelerated Bone Loss in Older Men: Effects on Bone Microarchitecture and Strength.

Authors:  Jane A Cauley; Andrew J Burghardt; Stephanie L Harrison; Peggy M Cawthon; Ann V Schwartz; Elizabeth Barrett Connor; Kristine E Ensrud; Lisa Langsetmo; Sharmila Majumdar; Eric Orwoll
Journal:  J Bone Miner Res       Date:  2018-06-12       Impact factor: 6.741

5.  A bone resorption marker as predictor of rate of change in femoral neck size and strength during the menopause transition.

Authors:  A Shieh; S Ishii; G A Greendale; J A Cauley; C Karvonen-Gutierrez; A S Karlamangla
Journal:  Osteoporos Int       Date:  2019-08-31       Impact factor: 4.507

6.  Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis.

Authors:  Mattias Lorentzon; Jaime Branco; Maria Luisa Brandi; Olivier Bruyère; Roland Chapurlat; Cyrus Cooper; Bernard Cortet; Adolfo Diez-Perez; Serge Ferrari; Andrea Gasparik; Markus Herrmann; Niklas Rye Jorgensen; John Kanis; Jean-Marc Kaufman; Andrea Laslop; Médéa Locquet; Radmila Matijevic; Eugene McCloskey; Salvatore Minisola; Richard Pikner; Jean-Yves Reginster; René Rizzoli; Pawel Szulc; Mila Vlaskovska; Etienne Cavalier
Journal:  Adv Ther       Date:  2019-08-22       Impact factor: 3.845

7.  Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial.

Authors:  Elizabeth M Curtis; Camille Parsons; Kate Maslin; Stefania D'Angelo; Rebecca J Moon; Sarah R Crozier; Fatma Gossiel; Nicholas J Bishop; Stephen H Kennedy; Aris T Papageorghiou; Robert Fraser; Saurabh V Gandhi; Ann Prentice; Hazel M Inskip; Keith M Godfrey; Inez Schoenmakers; M Kassim Javaid; Richard Eastell; Cyrus Cooper; Nicholas C Harvey
Journal:  Am J Clin Nutr       Date:  2021-11-08       Impact factor: 8.472

Review 8.  Clinical Utility of Biochemical Marker of Bone Turnover: Fracture Risk Prediction and Bone Healing.

Authors:  Byung-Ho Yoon; Woojin Yu
Journal:  J Bone Metab       Date:  2018-05-31

9.  Assessment of baseline bone turnover marker levels and response to risedronate treatment: Data from a Japanese phase III trial.

Authors:  Taro Mawatari; Satoshi Ikemura; Gen Matsui; Takahiro Iguchi; Hiroaki Mitsuyasu; Shinya Kawahara; Masayuki Maehara; Ryoichi Muraoka; Yukihide Iwamoto; Yasuharu Nakashima
Journal:  Bone Rep       Date:  2020-04-25

Review 10.  Potential Biomarkers to Improve the Prediction of Osteoporotic Fractures.

Authors:  Beom Jun Kim; Seung Hun Lee; Jung Min Koh
Journal:  Endocrinol Metab (Seoul)       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.